Conversely, pharmacological inhibition of these signaling axes attenuates the tumor-promoting effects observed in UGCG-overexpressing models, indicating that altered glycosphingolipid metabolism can sustain oncogenic signaling in a feed-forward manner [75,97,131]. Here, UGCG is linked to neoplasm.